About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit www.safemedicinesindia.in
PSM LOGO 17th December
News Archive
Quote of the day
Bejan Misra"Human Rights aren't just about violence and terrorism. Unsafe drugs too fall into the category. TheNational Human Rights Commission (NHRC) has described the manufacture, distribution and sale of unsafe drugs and medical devices as a violation of human rights." --Mr. Bejon Misra (Founder, PSM India)
In other News
FISHY FUNDRAISING for AIDS medicines

A professional fund-raising agency – the Canadian Organisation for International Philanthrophy, has been under the scanner for linking up with two charities in a supposed campaign to provide AIDS medicines in Africa.

The charities told donors they were buying AIDS medicines for $12 a dose, whereas other charities had been buying them from abroad for a fraction of the cost, at 30 to 40 cents a dose, according to investigative journalists from the Star.

Read more

Follow US on Faceboook
Follow US on twitter
This Newsletter brought to you by

Pharma secure Logo

National News
BAD BLOOD BANKS
Most of the private blood banks in the country do not comply with the provisions of the Drugs and Cosmetics Act of 1940, as per the findings of a survey conducted by a Chennai-based group that provides professional services to the pharmaceutical, blood bank, and medical devices industries.
Read More
FAKE COSMETICS NABBED IN NAGPUR
A racket involving the sale of counterfeit cosmetics has been busted in Nagpur by the city’s Crime Branch.
Read More
BLACKLISTED 9 FIRMS' DRUGS*

Hyderabad: Drugs of 9 pharmaceutical companies were found to be substandard and have been blacklisted by the Andhra Pradesh Medical Services and Infrastructure Development Corporation ( APMSIDC) .

Read More
Global News
A CLEAN CHIT FROM ARMENIA
SindoorArmeina’s Director of Scientific Centre of Drug and Medical Technology says his country’s pharmaceuticals, mostly imported from India and China, are practically free of counterfeit products.
Read More
CHINA’S CHALLENGE: ‘Made in China’ VACCINES
SindoorChina, which has demonstrated its vaccine manufacturing prowess globally, is poised to enter the international vaccine market in a big way in the coming years. However, more may be required than just the stern regulatory steps that the Chinese authorities have fashioned.
Read More
Pharma News
EVACETRAPIB Drug: The Cholesterol Regulator
A scientific investigation team headed by Cleveland Clinic’s Stephen J. Nicholls, M.B.B.S., Ph.D., has found that the use of the drug Evacetrapib is associated with a large increase in “good cholesterol”, i.e., high-density lipoprotein cholesterol, or HDL-C, a substance that is known to be associated with a lower incidence of cardiovascular disease.
Read More
INDIA PHARMACEUTICAL SUMMIT
SindoorThe Indian Pharmaceutical Summit 2011 was meant to prepare a road map on the challenges and opportunities facing the country as it gears to assume global leadership in generic medicine manufacture.
Read More
Drug Laws and Policy News
LETROZOL BANNED

SindoorA drug used to treat breast cancer in post-menopausal women – Letrozol, has been banned by the Government of India because its use as a fertility drug is believed to have resulted in babies with bone malformations and other complications.

Read More
MYELOFIBROSIS DRUG MAKES WAVES
The US Food and Drug Administration (FDA) has approved a new drug to treat Myleofibrosis, a bone marrow disease that causes spleen and liver enlargement and leads to anaemia and thrombocytopenia.
Read More
Valuable feedback to THE EDITOR - Pooja Khaitan
pooja@consumerconexion.org
Pooja Khaitan
© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065
www.safemedicinesindia.in; www.safemedicines.org; Consumer Conexion